JP2019518050A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518050A5
JP2019518050A5 JP2018565691A JP2018565691A JP2019518050A5 JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5 JP 2018565691 A JP2018565691 A JP 2018565691A JP 2018565691 A JP2018565691 A JP 2018565691A JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
compound
substituted
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018565691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518050A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/064654 external-priority patent/WO2017216283A1/en
Publication of JP2019518050A publication Critical patent/JP2019518050A/ja
Publication of JP2019518050A5 publication Critical patent/JP2019518050A5/ja
Pending legal-status Critical Current

Links

JP2018565691A 2016-06-16 2017-06-15 抗菌薬としての複素環式化合物 Pending JP2019518050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16174722 2016-06-16
EP16174722.5 2016-06-16
PCT/EP2017/064654 WO2017216283A1 (en) 2016-06-16 2017-06-15 Heterocyclic compounds as antibacte rials

Publications (2)

Publication Number Publication Date
JP2019518050A JP2019518050A (ja) 2019-06-27
JP2019518050A5 true JP2019518050A5 (enExample) 2020-08-13

Family

ID=56132839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018565691A Pending JP2019518050A (ja) 2016-06-16 2017-06-15 抗菌薬としての複素環式化合物

Country Status (12)

Country Link
US (1) US20200308169A1 (enExample)
EP (1) EP3472152A1 (enExample)
JP (1) JP2019518050A (enExample)
KR (1) KR20190018681A (enExample)
CN (1) CN109415349A (enExample)
AU (1) AU2017286370B2 (enExample)
BR (1) BR112018075939A2 (enExample)
CA (1) CA3025727A1 (enExample)
EA (1) EA201990044A1 (enExample)
MA (1) MA45375A (enExample)
MX (1) MX2018015657A (enExample)
WO (1) WO2017216283A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3316969T3 (pl) 2015-07-02 2022-06-20 Janssen Sciences Ireland Unlimited Company Związki przeciwbakteryjne
KR20180053386A (ko) 2015-09-17 2018-05-21 마빈 제이. 밀러 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물
BR112018076126A2 (pt) 2016-06-16 2019-03-26 Janssen Sciences Ireland Unlimited Company compostos heterocíclicos como antibacterianos
EP4417262A3 (en) 2017-03-01 2024-11-27 Janssen Sciences Ireland Unlimited Company Combination therapy
TWI861208B (zh) 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
ES2978573T3 (es) * 2019-09-13 2024-09-16 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos
KR20220071199A (ko) 2019-09-30 2022-05-31 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 4-퀴놀리논 항균 화합물
KR20220075335A (ko) 2019-09-30 2022-06-08 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 항균 화합물
AU2022237769A1 (en) 2021-03-16 2023-11-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
MX2023010948A (es) 2021-03-17 2023-11-28 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
CN117440958A (zh) 2021-03-17 2024-01-23 爱尔兰詹森科学公司 抗菌化合物
WO2022214520A1 (en) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2022214519A1 (en) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
JP2024540052A (ja) 2021-10-28 2024-10-31 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 細菌感染の治療に使用するためのイミダゾピリジンアミド及び関連化合物
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05001052A (es) 2002-07-25 2005-04-08 Janssen Pharmaceutica Nv Derivados de quinolina y su uso como inhibidores micobacterianos.
CN106866667B (zh) 2009-11-05 2019-11-15 圣母大学 咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
RU2576662C2 (ru) 2010-03-18 2016-03-10 Энститю Пастер Корея Противоинфекционные соединения
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
BR112014004560A2 (pt) 2011-09-01 2017-04-04 Irm Llc compostos e composições como inibidores de c-kit quinase
CA2879460C (en) 2012-07-18 2021-10-19 Garrett MORASKI 5,5-heteroaromatic anti-infective compounds
EP3027615B1 (en) 2013-08-02 2021-07-21 Institut Pasteur Korea Anti-infective compounds
CN105524058B (zh) 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2019518050A5 (enExample)
JP2019518046A5 (enExample)
JP2018519302A5 (enExample)
JP2018524339A5 (enExample)
JP2020169171A5 (enExample)
JP2019526596A5 (enExample)
JP2017524025A5 (enExample)
JP2014500295A5 (enExample)
JP2016530259A5 (enExample)
JP2019510787A5 (enExample)
JP2003128673A5 (enExample)
JP2013532652A5 (enExample)
MX2011002348A (es) Terapia de combinacion para tuberculosis.
HU229935B1 (en) Dual action antibiotics
JP2019527724A5 (enExample)
JP2007514691A5 (enExample)
JP2013542267A5 (enExample)
JP2020097577A5 (enExample)
JP2011526247A5 (enExample)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2019520344A5 (enExample)
JP2011509302A5 (enExample)
JP2021501756A5 (enExample)
JPWO2021030556A5 (enExample)
JP2018536678A5 (enExample)